iRhythm Technologies, Inc. (IRTC) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$117.70
Price Target
$193.67
Target Range
$160.00 — $255.00
Analyst Rating
Buy
Forward P/E—
Trailing P/E-84.7x
Forward PEG—
Implied Growth+64.6%
Median Target$184.00
Analyst Spread49.1%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$160
+35.9%
Consensus
$194
+64.5%
Bull Case
$255
+116.7%
IRTC Price Target Analysis
Updated May 7, 2026As of May 7, 2026, iRhythm Technologies, Inc. (IRTC) has a Wall Street consensus price target of $193.67, based on estimates from 19 covering analysts. With the stock currently trading at $117.70, this represents a potential upside of +64.5%. The company has a market capitalization of $3.87B.
Analyst price targets range from a low of $160.00 to a high of $255.00, representing a 49% spread in expectations. The median target of $184.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 16 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, IRTC trades at a trailing P/E of -84.7x. Analysts expect EPS to grow +64.6% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+39.2%
Avg Forward P/E14.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ITGRInteger Holdings Corporation | $3.0B | $86.29 | $98.00 | +13.6% | Buy | 13.3x | 14 |
 INVAInnoviva, Inc. | $1.9B | $22.52 | $37.67 | +67.3% | Buy | 11.8x | 10 |
 BDXBecton, Dickinson and Company | $52.4B | $144.76 | $172.85 | +19.4% | Buy | 11.6x | 33 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $79.00 | +3.9% | Hold | 17.2x | 42 |
 NVCRNovoCure Limited | $1.9B | $16.50 | $33.50 | +103.1% | Buy | — | 15 |
 MDTMedtronic plc | $99.5B | $77.60 | $109.50 | +41.1% | Buy | 14.1x | 49 |
 ABTAbbott Laboratories | $150.0B | $86.25 | $128.71 | +49.2% | Buy | 15.7x | 41 |
 BSXBoston Scientific Corporation | $83.2B | $56.00 | $91.33 | +63.1% | Buy | 16.6x | 43 |
 SJMThe J. M. Smucker Company | $10.3B | $96.83 | $113.38 | +17.1% | Hold | 10.7x | 29 |
 LIVNLivaNova PLC | $3.6B | $66.26 | $75.88 | +14.5% | Buy | 15.7x | 14 |
Upside Potential Comparison
NVCRINVABSXABTMDTBDXSJMLIVNSee IRTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IRTC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IRTC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIRTC — Frequently Asked Questions
Quick answers to the most common questions about buying IRTC stock.
What is the IRTC stock price target for 2026?
The consensus Wall Street price target for IRTC is $193.67, representing 64.5% upside from the current price of $117.7. With 19 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is IRTC a buy, sell, or hold?
IRTC has a consensus rating of "Buy" based on 19 Wall Street analysts. The rating breakdown is predominantly bullish, with 16 Buy/Strong Buy ratings. The consensus 12-month price target of $193.67 implies 64.5% upside from current levels.
Is IRTC stock overvalued or undervalued?
IRTC's current price is $117.7 with a consensus target of $193.67 (64.5% implied move). Analyst estimates suggest the stock is undervalued at current levels.
How high can IRTC stock go?
The most bullish Wall Street analyst has a price target of $255 for IRTC, while the most conservative target is $160. The consensus of $193.67 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover IRTC stock?
IRTC is well covered by analysts, with 19 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the IRTC stock forecast?
The 12-month IRTC stock forecast based on 19 Wall Street analysts shows a consensus price target of $193.67, with estimates ranging from $160 (bear case) to $255 (bull case). The median consensus rating is "Buy".
Should I buy IRTC stock?
Wall Street analysts are very optimistic on IRTC, with a "Buy" consensus rating and $193.67 price target (64.5% upside). 16 of 19 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do IRTC price targets vary so much?
IRTC analyst price targets range from $160 to $255, a 49% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $193.67 consensus represents the middle ground.